Cardiovascular and Endocrine Response to Muscular Training Program of Young Soccer Players Aged 14-18 Years

NCT06451367 | Not Yet Recruiting DMC

• 1 other identifier: YoungSoccer_14-18
• Study Type: interventional
• Target: 30
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study focuses on understanding the cardiovascular and endocrine responses of young soccer players aged 14 to 18 years to a muscular training program. Adolescence is a critical period for physiological development, and investigating these responses can provide insights crucial for athletic performance and overall health. The benefits include promoting overall health, reducing injury risk, and enhancing scientific knowledge. However, intensive training programs may lead to overtraining and potential negative health outcomes if not carefully monitored. The study aims to assess whether additional neuromuscular development over 12 weeks can enhance players' physical fitness and hormonal changes. By examining these outcomes, the study seeks to inform evidence-based training protocols for optimizing adolescent athletes' health and performance in soccer. The study design involves a prospective single-center randomized cohort to investigate these responses comprehensively.

Conditions

Sport Injury; Hormone Disturbance; Cardiovascular Abnormalities

Outcome Measures

Primary Outcomes (3)

• VO2 max, lactate

  The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as maximum oxygen uptake (VO2max in mL/kg/min with capillary lactate measurement in mmol/L)

  Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

• Heart rate variability

  The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as heart rate variability (HRV in ms).

  Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

• Body composition

  The study aims to examine the effects of a 12-week supplemental muscle program on cardiopulmonary exercise testing, focusing on key metrics such as body composition (percentage of body fat, muscle mass in kg). Height will be measured in centimeters (cm) and weight in kilograms (kg) to calculate the Body Mass Index (BMI) in kg/m²

  Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

Secondary Outcomes (2)

• Hormonal changes: Cortisol

  Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

• Hormonal changes: Testosterone

  Before the start of the 12-week muscular training program (pre-intervention) and immediately after the 12-week intervention (post-intervention).

Study Arms (2)

Intervention

EXPERIMENTAL

Regular football training and neuromuscular training program for 12 weeks

Other: neuromuscular programm

Controle

NO INTERVENTION

Regular football training

Interventions

neuromuscular programm OTHER

neuromuscular programm during 12 weeks (3 times a week, 10 minutes each time)

Intervention

Eligibility Criteria

• Age: 14 Years - 18 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Engaging in a football training program.
• No history of injuries in the last 6 months requiring surgical intervention.
• No intake of anabolic supplements.
• Age 14-18 years old.
• Normal BMI (18.5 - 24.9 kg/m²).
• Parents and participants must consent to receive all pertinent information discovered during the study, such as potential cardiovascular diseases or hormonal disorders.
• Participants must also consent to the sharing of certain private information with their parents or legal guardians. This includes information regarding cannabis use, as well as the consumption of anabolic steroids and other controlled substances. This additional consent ensures transparency and openness in sharing relevant health-related information with parents or legal guardians, particularly for participants under 18 years of age.
• For participants under the age of 18, parental consent or consent from a legal guardian is mandatory in addition to the participant's consent. This ensures that minors have parental approval to take part in the study.
• All participants, regardless of age, must provide their voluntary consent to participate in the study. For participants under the age of 18, consent from one of their parents or legal guardians is also required in addition to the participant's consent.

You may not qualify if:

• Engaging in other supplemental individual exercise programs.
• Being a smoker (\>1 cigarette/week).
• Using any medication at the time of testing.
• Having any disease.

Sponsors & Collaborators

• Hôpital Fribourgeois: lead

MeSH Terms

Conditions

Endocrine System Diseases; Cardiovascular Abnormalities

Condition Hierarchy (Ancestors)

Cardiovascular Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Maristella Santi, Dr. med

CONTACT

079 720 95 20; maristella.santi@h-fr.ch

Johannes Wildhaber-Brooks, Prof. Dr. med.

CONTACT

026 306 00 00; maristella.santi@h-fr.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Participants are randomly assigned to either a control group or an intervention group (N=30, with 15 participants in each group). This study focuses on football players aged 14 to 18 who are part of the elite team of the football society of Fribourg, Switzerland. In the control group, participants engage exclusively in regular football training, whereas participants in the intervention group also participate in a 12-week neuromuscular development program. Measurements Before and after the intervention, various measurements are taken for each participant, including: Blood steroid profile Heart rate variability Lung function using ergospirometry (VO2 max with lactate) Body composition using the Inbody 770 machine Muscular strength using a Newton measurement

Study Record Dates

• First Submitted: May 27, 2024
• First Posted: June 11, 2024
• Study Start: June 28, 2024
• Primary Completion: October 30, 2024
• Study Completion: December 31, 2024
• Last Updated: June 24, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share